Author: pluginever

What's a stock you're down on significantly but you still have strong conviction it will be go up in the long-run? Mine would be MRNA, i'm down close to 50% on it but I still believe in the future of the MRNA technology and their branding over the long-term, they have a ton of things…

Should I invest in one of these courses where they teach and you trade along side etc if so do you know of any good reliable ones. Should I just stick in on something like voo and take small profits. Or have a go at options I have some experience in understanding how to buy…

Hello, I have been researching and looking at various data concerning call/put options. To better understand different scenarios I used a calculator that I found very detailed to better visualize many outcomes. Call option Calculator: https://www.optionsprofitcalculator.com/calculator/long-call.html For 2 different scenarios I used the same stock price but with a different Strike. I set a range…

Hey everyone, I'm interested in diversifying (and adding risk to my SP500&all-world etf dominated portfolio) my portfolio a bit and looking into some European small-cap growth stocks. I'm curious if any of you have any promising companies on your radar at the moment. I'm particularly interested in companies with: Innovative products/services & Potential for significant…

Viking Therapeutics MC – $7 billion Zealand Pharmaceuticals MC – $9 billion Madrigal Pharmaceuticals MC – $5.5 billion Altimmune MC – $493 million Can someone explain this discrepancy to me? Pretty much all of these companies are in almost the same phase of clinical trials for their Obesity/MASH drugs aside from Madrigal. Madrigal has an…

Hello everyone, I was recently checking Match’s 10-K and saw that half of the company is held by IAC Interactive ($IAC) . But IAC has market cap of only 1bn USD. Match alone is worth 10bn USD (so IAC owns 5bn) so you’re essentially getting 5bn – 1bn = 4bn of free match stock? Someone…

Nebius Group N.V. (NBIS), formerly known as Yandex N.V., the Dutch parent company of the Nebius Group, announced the completion of its name and stock ticker change from Yandex N.V. (YNDX). “As of August 21, 2024, all stock trading, filings, and market related information will be reported under the new symbol NBIS. Trading in the…

This is the daily discussion, so anything stocks related is fine, but the theme for today is on fundamentals, but if fundamentals aren't your thing then just ignore the theme. Some helpful day to day links, including news: Finviz for charts, fundamentals, and aggregated news on individual stocks Bloomberg market news StreetInsider news: Market Check…

Tempus AI is at the forefront of a healthcare revolution, leveraging artificial intelligence to drive breakthroughs in precision medicine. Their platform integrates and analyzes vast amounts of clinical and molecular data to personalize cancer treatment and improve patient outcomes. This data-driven approach has the potential to reshape the way we treat complex diseases. What makes…

Every few months, I come across someone sharing a bullish outlook on $MSOS, but the comments section always seems to be filled with negativity. The ETF’s underlying holdings, like Trulieve and Green Thumb, which account for nearly 40% of its portfolio, are fundamentally strong. Both companies have shown steady EBITDA growth and have maintained their…